Ernexa Therapeutics Inc. (ERNA) Current Leases (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Current Leases came in at $163000.0 in Q1 2026, down 23.47% YoY from $213000.0 in Q1 2025, and down 23.47% on a QoQ basis from $213000.0 in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Current Leases (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 17 years of Current Leases data on file, last reported at $163000.0 in Q1 2026.
- Quarterly Current Leases fell 23.47% year-over-year to $163000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163000.0 (down 23.47% YoY) and the FY2025 annual result came in at $213000.0, up 2.9% from the prior year.
- Current Leases eased to $163000.0 in Q1 2026, from $213000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.3 million in Q2 2024 to a low of $149000.0 in Q1 2022.
- A 5-year average of $796235.3 and a median of $213000.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases soared 2365.9% — and 2025, when it slumped 94.91%.
- Tracing ERNA's Current Leases over 5 years: stood at $295000.0 in 2022, then jumped by 651.19% to $2.2 million in 2023, then sank by 90.66% to $207000.0 in 2024, then gained by 2.9% to $213000.0 in 2025, then fell by 23.47% to $163000.0 in 2026.
- The last three Current Leases figures came in at $163000.0 (Q1 2026), $213000.0 (Q4 2025), and $206000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167,000.00 |
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 213,000.00 |
| Sep 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | 207,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 295,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 149,000.00 |
| Dec 31, 2021 | 426,000.00 |
| Sep 30, 2021 | 408,125.00 |